TGF Beta Inhibition for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|6|7|565-578

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.6, Iss.7, 2006-11, pp. : 565-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TGF-beta Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2934-2947

Bentham Science Publishers

Access to resources Recommend Favorite

TGF-Beta Signaling Manipulation as Potential Therapy for IBD

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1400-1404

Bentham Science Publishers

Access to resources Recommend Favorite

From TGF-&bgr; to Cancer Therapy

By  

Current Drug Targets, Vol. 4, Iss. 3, 2003-01 ,pp. : 243-250

Bentham Science Publishers

Access to resources Recommend Favorite

RET inhibition: implications in cancer therapy

By Borrello Maria Grazia   Ardini Elena   Locati Laura D   Greco Angela   Licitra Lisa   Pierotti Marco A  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 4, 2013-04 ,pp. : 403-419

Informa Healthcare

Access to resources Recommend Favorite

Selective Raf inhibition in cancer therapy

By Khazak Vladimir   Astsaturov Igor   Serebriiskii Ilya G   Golemis Erica A  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1587-1609

Informa Healthcare

Access to resources Recommend Favorite